UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma

Leukemia & lymphoma, 2018-06, Vol.59 (6), p.1420-1426

2018

Volltextzugriff (PDF)

The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

Annals of the rheumatic diseases, 2010-03, Vol.69 (3), p.598-605

2010

Volltextzugriff (PDF)

Rituximab With Or Without Chlorambucil For The Treatment Of Extranodal Marginal Zone B-Cell Lymphoma (MALT Lymphoma) Results From a Monocentric Study

Blood, 2013-11, Vol.122 (21), p.5132-5132

2013

Volltextzugriff (PDF)

RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology

Journal of rheumatology, 2012-08, Vol.39 (8), p.1678

2012

Volltextzugriff (PDF)

First Line Treatment with Bendamustine in Selected Non Hodgkin’s Lymphoma Patients: Prospective Experience in Tuscany Region

Blood, 2014-12, Vol.124 (21), p.5451-5451

2014

Volltextzugriff (PDF)

The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas

World journal of nuclear medicine, 2018-07, Vol.17 (3), p.157-165

2018

Volltextzugriff (PDF)

Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma

Leukemia & lymphoma, 2014-09, Vol.55 (9), p.2071-2078

2014

Volltextzugriff (PDF)

HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides

Annals of the New York Academy of Sciences, 2009-09, Vol.1173 (1), p.570-574

2009

Volltextzugriff (PDF)

Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma

Blood, 2011-11, Vol.118 (21), p.2478-2478

2011

Volltextzugriff (PDF)

Evidence for the prevention of enthesitis in HLA‐B27/hβ2m transgenic rats treated with a monoclonal antibody against TNF‐α

Journal of cellular and molecular medicine, 2011-02, Vol.15 (2), p.270-279

2011

Volltextzugriff (PDF)

The gastric wall in systemic sclerosis patients: a morphological study

Italian journal of anatomy and embryology, 2010, Vol.115 (1-2), p.115

2010

Volltextzugriff (PDF)

HLA-B27 Transgenic Rat

Annals of the New York Academy of Sciences, 2009-09, Vol.1173 (1), p.570-574

2009

Volltextzugriff (PDF)

TNFα blockade prevents the development of inflammatory bowel disease in HLA‐B27 transgenic rats

Journal of cellular and molecular medicine, 2009-01, Vol.13 (1), p.164-176

2009

Volltextzugriff (PDF)

TNF[alpha] blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats

Journal of cellular and molecular medicine, 2009-01, Vol.13 (1), p.164

2009

Volltextzugriff (PDF)

Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α

Journal of cellular and molecular medicine, 2011-02, Vol.15 (2), p.270-279

2011

Volltextzugriff (PDF)

TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats

Journal of cellular and molecular medicine, 2009-01, Vol.13 (1), p.164-176

2009

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(7)
Life Sciences & Biomedicine
(6)
Science & Technology
(6)
Female
(5)
Male
(5)
Ibd
(4)
Adult
(3)
Aged
(3)
Animals
(3)
Hematology
(3)
Hla-B27 Antigen - Genetics
(3)
Hla-B27 Antigen - Immunology
(3)
Hla-B27 Transgenic Rats
(3)
Hla‐b27 Transgenic Rats
(3)
Inflammatory Bowel Disease
(3)
Inflammatory Bowel Diseases - Immunology
(3)
Middle Aged
(3)
Rats
(3)
Rats, Transgenic
(3)
Spa
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma

The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

Rituximab With Or Without Chlorambucil For The Treatment Of Extranodal Marginal Zone B-Cell Lymphoma (MALT Lymphoma) Results From a Monocentric Study

RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology

First Line Treatment with Bendamustine in Selected Non Hodgkin’s Lymphoma Patients: Prospective Experience in Tuscany Region

Role of Genetic Polymorphisms on Response to R-Chopregimen in Diffuse Large B-Cell Lymphoma Patients: An Interim Analysis of a Multicenter Prospective Pharmacogenetic Study

The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas

Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma

HLA-B27 transgenic rat: an animal model mimicking gut and joint involvement in human spondyloarthritides

Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma

R-CHOP21 Vs R-CHOP14 in 950 Diffuse Large B-Cell Lymphoma Patients: Results of a Multicentre Retrospective Study Form Italian Lymphoma Foundation (FIL)

Evidence for the prevention of enthesitis in HLA‐B27/hβ2m transgenic rats treated with a monoclonal antibody against TNF‐α

The gastric wall in systemic sclerosis patients: a morphological study

HLA-B27 Transgenic Rat

TNFα blockade prevents the development of inflammatory bowel disease in HLA‐B27 transgenic rats

TNF[alpha] blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats

Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α

TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats

Suchergebnisse filtern